Not Found: wait
Clinical Trials
Register
Workgroups
For Patients
Events
About us
Contact Persons
Organisationen
Sponsors
Publications
Scores
Login
de
en
Clinical Trials of the German Lymphoma Alliance
Study status
planned, Recruiting will start shortly
Recruiting started / enrolling patients
Recruitment goal achieved/no new patients
Indication
Posttransplantations-Lymphom
ZNS Lymphom
DLBCL
T-Zell Lymphom
Marginalzonenlymphom
Morbus Waldenström
Follikuläres Lymphom
Mantelzell- Lymphom
Age of Patients
18 -60 Jahre
> 60 Jahre
Therapy phase
Erstlinie / Primärtherapie
Rezidiv / Rückfalltherapie
Study sponsor
Academic study by the GLA
Study of the pharmaceutical industry with GLA leadership
Study phase
Basket Phase I/II
Phase I
Phase II
Phase III
Phase IV
Akademische Studien der GLA
Alternative C - GLA 2020-2
ARCHED - GLA 2022-1
ASTRAL - GLA 2019-5
Charly - GLA 2017-4
COPA-R-CHOP - GLA 2020-1
COUP-1 - GLA 2019-3
CZAR-1 - GLA 2021-2
ECWM-1 - GLA 2014-1
ECWM-2 - GLA 2019-2
FORTplus - GLA 2022-5
GAZAI - GLA 2018-3
GDL-ISRT 20 Gy - GLA 2019-4
GOAL-II - GLA 2021-1
ImbruVeRCHOP-Trial - GLA 2017-2
MARTA - GLA 2017-1
MATRix - IELSG43 - GLA 2014-3
MCL Elderly III - GLA 2022-3
MCL R2 elderly - GLA 2015-2
MMML Predict - GLA 2022-8
Niveau - GLA 2018-1
OLYMP-1 - GLA 2019-1
OPTIMAL - GLA 2011-1
OptiMATe - GLA 2021-4
Pola-R-ICE - GLA 2021-3
POLE-1 - GLA 2022-4
PRIMA-CNS - GLA 2022-2
PTLD 2 - GLA 2015-1
R-CHOEP brut - GLA 2018-2
ReBeL - GLA 2014-2
TRIANGLE - GLA 2016-1
VALIDATE - GLA 2021-5
VenObi - GLA 2020-3
VIWA-1 - GLA 2022-6
Studien der pharmazeutischen Industrie mit GLA-Leitung
AR-CHOP-21
CELESTIMO
DALY 2 EU
EZH-302
inMIND